Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gavin Wood currently holds 2,544,432 shares of Adaptimmune Therapeutics PLC (ADAP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gavin Wood has been a net seller of ADAP stock. They have purchased $81.3K and sold $581.5K worth of shares.
Gavin Wood's most recent insider trade was on Sep 2, 2025, when they sold 96,000 shares at $0.01 per share.
Gavin Wood serves as Executive at Adaptimmune Therapeutics PLC (ADAP). They have executed 47 insider transactions totaling $662.9K over their tenure at the company.
Gavin Wood holds the position of Executive at Adaptimmune Therapeutics PLC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Gavin Wood has shown a selling trading pattern, with $81.3K in total purchases and $581.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gavin Wood was on Jan 20, 2015, when they sold $264.8K worth of AFFX shares. This transaction involved 22,500 shares at $11.77 per share.
Gavin Wood currently owns 2,544,432 shares of Adaptimmune Therapeutics PLC (ADAP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gavin Wood's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gavin Wood has 47 Form 4 filings on record as an insider at Adaptimmune Therapeutics PLC.
Set alerts for Gavin Wood and 40,000+ other insiders.